<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03001180</url>
  </required_header>
  <id_info>
    <org_study_id>CCHMC-LMI</org_study_id>
    <nct_id>NCT03001180</nct_id>
  </id_info>
  <brief_title>Identification of Biomarkers for Patients With Vascular Anomalies</brief_title>
  <official_title>Identification of Biomarkers for Patients With Vascular Anomalies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lymphangiomatosis and Gorham's Disease Alliance (LGDA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klippel Trenaunay (KT) Support Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CLOVES Syndrome Community Support Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will use participants tissue previously collected and stored in a tissue bank
      maintained by the Department of Hematology/Oncology as well as tissue banked in the future
      from participants undergoing prescribed surgical resection of vascular anomalies of interest
      proposed in this study. The principle investigator and study staff will also obtain blood
      from these participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      While vascular anomalies are rare diseases, they can be life-threatening and devastating to
      affected children and their families. Advances in diagnosis, monitoring and therapies will be
      significantly improved if non-invasive biomarkers that are sensitive and specific can be
      identified. Obtaining a tissue biopsy to help in diagnosis can actually worsen the disease
      and so identification of specific blood biomarkers is highly desirable. Studies will measure
      angiogenic factors in serum and plasma samples at baseline and on therapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <primary_completion_date type="Anticipated">January 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of Biomarkers with Differential Diagnosis</measure>
    <time_frame>An Average of Every 2 Years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of Biomarkers with Disease Severity</measure>
    <time_frame>An Average of Every 2 Years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of Biomarkers with Response to Therapies</measure>
    <time_frame>An Average of Every 2 Years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Vascular Anomaly</condition>
  <condition>Generalized Lymphatic Anomaly</condition>
  <condition>Kaposiform Hemangioendothelioma</condition>
  <condition>Kaposiform Lymphangiomatosis</condition>
  <condition>Gorham-Stout Disease</condition>
  <condition>Klippel Trenaunay Syndrome</condition>
  <condition>Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue, Blood, Plasma, and Serum Samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Any participant having labs drawn as standard of care will have blood drawn for the study
        if consented/assented. All participants who are undergoing a surgical procedure or
        sclerotherapy are currently consented for participation in the tissue bank. The principle
        investigator will be looking at tissue from these participants. There is no further
        recruitment for the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient having labs drawn as standard of care will have blood drawn for the study
             if consented/ assented.

          -  All patients who are undergoing a surgical procedure or sclerotherapy are currently
             consented for participation in the tissue bank.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy LeCras, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Timothy LeCras, PhD</last_name>
    <phone>5138034862</phone>
    <email>hvmcresearch@cchmc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paula Mobberley-Schuman</last_name>
    <phone>5138034862</phone>
    <email>hvmcresearch@cchmc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justyna Klajn</last_name>
      <phone>617-355-2901</phone>
      <email>justyna.klajn@childrens.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Denise Adams, MD</last_name>
      <phone>617-919-1761</phone>
      <email>denise.adams@childrens.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Denise Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Mobberley-Schuman, MS</last_name>
      <phone>513-803-4862</phone>
      <email>hvmcresearch@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Timothy LeCras, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrienne Hammill, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2016</study_first_submitted>
  <study_first_submitted_qc>December 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2016</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Generalized Lymphatic Anomaly</keyword>
  <keyword>Vascular Anomaly</keyword>
  <keyword>Kaposiform Hemangioendothelioma</keyword>
  <keyword>Kaposiform Lymphangiomatosis</keyword>
  <keyword>Vascular Endothelial Growth Factor</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>GLA</keyword>
  <keyword>KLA</keyword>
  <keyword>KHE</keyword>
  <keyword>GSD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
    <mesh_term>Hemangioendothelioma</mesh_term>
    <mesh_term>Sarcoma, Kaposi</mesh_term>
    <mesh_term>Kasabach-Merritt Syndrome</mesh_term>
    <mesh_term>Klippel-Trenaunay-Weber Syndrome</mesh_term>
    <mesh_term>Osteolysis, Essential</mesh_term>
    <mesh_term>Lipoma</mesh_term>
    <mesh_term>Musculoskeletal Abnormalities</mesh_term>
    <mesh_term>Nevus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

